Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Another program may show a low starting rate
Complete this form to get your journey started today
Trial of lixisenatide in early Parkinson's disease
Sequential [ 177 Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study
Retatrutide vs Tesamorelin Tesamorelin is a stabilised GHRH analogue it acts upstream at the growth-hormone-releasing-hormone receptor, influencing the pulsatile release of growth hormone, with downstream research interest in lipid and visceral-adipose metabolism
- Are there any specific instructions or precautions I should follow
US$ 24.83
US$ 20.99
US$ 26.19
US$ 27.89
US$ 26.58
US$ 22.85
US$ 20.72
US$ 24.49
US$ 29.74
US$ 20.45
US$ 23.30
